Diverse, high-quality test set for the validation of protein-ligand docking performance

被引:500
作者
Hartshorn, Michael J. [1 ]
Verdonk, Marcel L. [1 ]
Chessari, Gianni [1 ]
Brewerton, Suzanne C. [1 ]
Mooij, Wijnand T. M. [1 ]
Mortenson, Paul N. [1 ]
Murray, Christopher W. [1 ]
机构
[1] Astex Therapeut Ltd, Cambridge CB4 0QA, England
关键词
D O I
10.1021/jm061277y
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A procedure for analyzing and classifying publicly available crystal structures has been developed. It has been used to identify high-resolution protein-ligand complexes that can be assessed by reconstructing the electron density for the ligand using the deposited structure factors. The complexes have been clustered according to the protein sequences, and clusters have been discarded if they do not represent proteins thought to be of direct interest to the pharmaceutical or agrochemical industry. Rules have been used to exclude complexes containing non-drug-like ligands. One complex from each cluster has been selected where a structure of sufficient quality was available. The final Astex diverse set contains 85 diverse, relevant protein-ligand complexes, which have been prepared in a format suitable for docking and are to be made freely available to the entire research community (http://www.ccdc.cam.ac.uk). The performance of the docking program GOLD against the new set is assessed using a variety of protocols. Relatively unbiased protocols give success rates of approximately 80% for redocking into native structures, but it is possible to get success rates of over 90% with some protocols.
引用
收藏
页码:726 / 741
页数:16
相关论文
共 137 条
[11]   Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): Design, synthesis, enzymatic activities, and X-ray crystallographic analysis [J].
Bramson, HN ;
Corona, J ;
Davis, ST ;
Dickerson, SH ;
Edelstein, M ;
Frye, SV ;
Gampe, RT ;
Harris, PA ;
Hassell, A ;
Holmes, WD ;
Hunter, RN ;
Lackey, KE ;
Lovejoy, B ;
Luzzio, MJ ;
Montana, V ;
Rocque, WJ ;
Rusnak, D ;
Shewchuk, L ;
Veal, JM ;
Walker, DH ;
Kuyper, LF .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (25) :4339-4358
[12]   Virtual screening for submicromolar leads of tRNA-guanine transglycosylase based on a new unexpected binding mode detected by crystal structure analysis [J].
Brenk, R ;
Naerum, L ;
Grädler, U ;
Gerber, HD ;
Garcia, GA ;
Reuter, K ;
Stubbs, MT ;
Klebe, G .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (07) :1133-1143
[13]   Structural characterization and kinetics of nitric-oxide synthase inhibition by novel N5-(iminoalkyl)- and N5-(iminoalkenyl)-ornithines [J].
Bretscher, LE ;
Li, HY ;
Poulos, TL ;
Griffith, OW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (47) :46789-46797
[14]   Structural basis for inhibition of Escherichia coli uridine phosphorylase by 5-substituted acyclouridines [J].
Bu, WM ;
Settembre, EC ;
el Kouni, MH ;
Ealick, SE .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2005, 61 :863-872
[15]   Crystal structure of quinone reductase 2 in complex with resveratrol [J].
Buryanovskyy, L ;
Fu, Y ;
Boyd, M ;
Ma, YL ;
Hsieh, TC ;
Wu, JM ;
Zhang, ZT .
BIOCHEMISTRY, 2004, 43 (36) :11417-11426
[16]   Structural basis for the activity of drugs that inhibit phosphodiesterases [J].
Card, GL ;
England, BP ;
Suzuki, Y ;
Fong, D ;
Powell, B ;
Lee, B ;
Luu, C ;
Tabrizizad, M ;
Gillette, S ;
Ibrahim, PN ;
Artis, DR ;
Bollag, G ;
Milburn, MV ;
Kim, SH ;
Schlessinger, J ;
Zhang, KYJ .
STRUCTURE, 2004, 12 (12) :2233-2247
[17]   Evaluating molecular-docking methods for pose prediction and enrichment factors [J].
Chen, HM ;
Lyne, PD ;
Giordanetto, F ;
Lovell, T ;
Li, J .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2006, 46 (01) :401-415
[18]   Phosphinic derivatives as new dual enkephalin-degrading enzyme inhibitors:: Synthesis, biological properties, and antinociceptive activities [J].
Chen, HX ;
Noble, F ;
Mothé, A ;
Meudal, H ;
Coric, P ;
Danascimento, S ;
Roques, BP ;
George, P ;
Fournié-Zaluski, MC .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (07) :1398-1408
[19]   Structure determination of tetrahydroquinazoline antifolates in complex with human and Pneumocystis carinii dihydrofolate reductase:: correlations between enzyme selectivity and stereochemistry [J].
Cody, V ;
Luft, JR ;
Pangborn, W ;
Gangjee, A ;
Queener, SF .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2004, 60 :646-655
[20]   Potential tumor-selective nitroimidazolylmethyluracil prodrug derivatives: Inhibitors of the angiogenic enzyme thymidine phosphorylase [J].
Cole, C ;
Reigan, P ;
Gbaj, A ;
Edwards, PN ;
Douglas, KT ;
Stratford, IJ ;
Freeman, S ;
Jaffar, M .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (02) :207-209